Blue Trust’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Other funds holding LGND
Blue Trust's LGND Position: Q3 2026 in Review
Blue Trust held its Ligand Pharmaceuticals (LGND) position steady in Q3 2026 at 3 shares worth $937. The position accounts for ﹤0.01% of the portfolio, ranked #2181.
Blue Trust first reported a position in LGND in Q4 2023 and has held it in 7 quarters since. The position peaked at $4.72K in Q3 2024. 359 funds tracked by Wall St. Rank hold LGND as of Q3 2026.
- Blue Trust held 3 shares of Ligand Pharmaceuticals worth $937 as of Q3 2026.
- Blue Trust left its Ligand Pharmaceuticals share count unchanged in Q3 2026.
- Ligand Pharmaceuticals made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #2181 holding.
- Blue Trust first reported a position in Ligand Pharmaceuticals in Q4 2023 and has held it in 7 quarters since.
- Blue Trust's Ligand Pharmaceuticals position peaked at $4.72K in Q3 2024.
- 359 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.